Fingerprint
Dive into the research topics of 'Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia
Robert J. Kreitman, Maryalice Stetler-Stevenson, Inger Margulies, Pierre Noel, David J.P. FitzGerald, Wyndham H. Wilson, Ira Pastan
Research output: Contribution to journal › Article › peer-review
174
Scopus
citations